WEAVWeave Communications, Inc.
Is the price fair?
Growth expectations in line with delivery. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Priced for ~15% a year FCF growth. Roughly in line with its three-year revenue growth of 18% a year.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What WEAV's price assumes
- Free cash flow yield
- 2.4%
Free cash flow yield · Health Information Services median 6.3%
- Growth the price implies
- +15%
Growth the price implies · The price pays for +15% free cash flow growth a year for a decade; revenue has grown +18% a year over the last three.
Details›
- EV / EBIToperating margin −8.3%: the multiple describes the denominator
- not meaningful
- Free cash flow, trailing twelve months
- $14M
- Market capitalisation
- $588M
- 3-year revenue growth
- +18%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #18 of 20 by RyuScore